The Company's full financial statements and related MD&A for the first quarter ended September 30, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary ...

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a ...

Detailed price information for Inmed Pharmaceuticals Inc (INM-Q) from The Globe and Mail including charting and trades.

His term at INM proved controversial ... “The application of the legislation needs to be reviewed, as it is grossly unfair that the CEO of a company can make a protected disclosure without ...

INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, announced that ...

INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the ...

At a remote military checkpoint in the Mexican desert some 25 miles (40 km) south of the border city of Ciudad Juarez, ...

INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced ...

The Republican former president won over voters with promises that his brand of America-first economic populism would make ...

In response, the Biden administration closed several commercial border ports, including busy Texas railway bridges in El Paso ...

In response, the Biden administration closed several commercial border ports, including busy Texas railway bridges in El Paso and Eagle Pass on Dec. 18, citing the need to redirect personnel to ...